Previous close | 84.65 |
Open | 84.82 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1100 |
Day's range | 83.96 - 85.56 |
52-week range | 62.11 - 97.49 |
Volume | |
Avg. volume | 2,220,581 |
Market cap | 21.444B |
Beta (5Y monthly) | 1.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.60 (1.90%) |
Ex-dividend date | 21 Mar 2024 |
1y target est | N/A |
NEW YORK, May 01, 2024--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024.
IFF's Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15, Gaylord Palms Resort and Convention Center, Kissimmee, Florida at booth 214.
NEW YORK, April 16, 2024--IFF (NYSE:IFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.